Clinical Trial

AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images

Study acronym: Atheroscope
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Cardiovascular risk scores are widely used for risk stratification but may fail to identify a substantial proportion of individuals with subclinical atherosclerosis who are at increased risk of future cardiovascular events. Vascular ultrasound can directly detect carotid and femoral atherosclerotic plaques but its implementation is limited by the need for trained operators and expert interpretation. The AI-THEROSCOPE study aims to develop and validate an artificial intelligence-based tool capable of detecting subclinical atherosclerosis through the analysis of non-mydriatic retinal fundus images. Participants undergo clinical assessment, laboratory testing, carotid and femoral ultrasound, and retinal fundus photography. The performance of the AI model will be evaluated against vascular ultrasound findings as the reference standard for the presence of subclinical atherosclerosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-01.
Trial Details
NCT Number NCT07628088
Lead Sponsor Infanta Leonor University Hospital
Conditions Subclinical Atherosclerosis, Cardiovascular Risk
Enrollment 884 participants
Start Date 2023-10-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10